Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:515-522
Published online before print August 28, 2003, doi: 10.1161/01.RES.0000093205.42313.7C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/6/515    most recent
01.RES.0000093205.42313.7Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaub, F. J.
Right arrow Articles by Bowen-Pope, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaub, F. J.
Right arrow Articles by Bowen-Pope, D. F.
Related Collections
Right arrow Apoptosis
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2003;93:515.)
© 2003 American Heart Association, Inc.


Molecular Medicine

Fas and Fas-Associated Death Domain Protein Regulate Monocyte Chemoattractant Protein-1 Expression by Human Smooth Muscle Cells Through Caspase- and Calpain-Dependent Release of Interleukin-1{alpha}

Friedemann J. Schaub, W. Conrad Liles, Nicola Ferri, Kirsten Sayson, Ronald A. Seifert, Daniel F. Bowen-Pope

From the Departments of Pathology (F.J.S., W.C.L., N.F., K.S., R.A.S., D.F.B.-P.) and Medicine (W.C.L.), University of Washington, Seattle, Wash.

Correspondence to Daniel F. Bowen-Pope, University of Washington, Department of Pathology, Box 357470, Seattle, WA 98195-7470. E-mail: bp{at}u.washington.edu

We previously reported that treatment of human vascular smooth muscle cells (SMCs) with proapoptotic stimuli, including Fas ligand plus cycloheximide (FasL/Chx), or overexpression of Fas-associated death domain protein (FADD) result in increased expression of monocyte chemoattractant protein-1 (MCP-1) and other proinflammatory genes. In this study, we demonstrate that Fas/FADD-induced MCP-1 upregulation is driven by an autocrine/paracrine signaling loop in which interleukin (IL)-1{alpha} synthesis and release are activated through caspase- and calpain-dependent processes. Untreated SMCs contain very little IL-1{alpha} protein or transcript. Both were increased greatly in response to Fas/FADD activation, primarily through an autocrine/paracrine pathway in which secreted IL-1{alpha} stimulated additional IL-1{alpha} synthesis and release. Caspase 8 (Csp8) activity increased in response to FasL/Chx treatment, and Csp8 inhibitors markedly reduced IL-1{alpha} release and MCP-1 upregulation. In contrast, Csp8 activity was not significantly increased in response to FADD overexpression and caspase inhibitors did not effect FADD-induced MCP-1 upregulation. Both FasL/Chx treatment and FADD overexpression increased the activity of calpains. Calpain inhibitors reduced IL-1{alpha} release and MCP-1 upregulation in both FADD-overexpressing SMCs and FasL/Chx-treated SMCs without blocking Csp8 activity. This indicates that calpains are not required for activation of caspases and that caspase activation is not sufficient for IL-1{alpha} release and MCP-1 upregulation. These data suggest that calpains play a dominant role in Fas/FADD-induced IL-1{alpha} release and MCP-1 upregulation and that caspase activation may function to amplify the effects of calpain activation.


Key Words: apoptosis • interleukin • inflammation • calpain • monocyte chemoattractant protein-1




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
W. A. Altemeier, X. Zhu, W. R. Berrington, J. M. Harlan, and W. C. Liles
Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway
J. Leukoc. Biol., September 1, 2007; 82(3): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Schultz, V. Murthy, J. B. Tatro, and D. Beasley
Endogenous interleukin-1{alpha} promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2927 - H2934.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. M. Buga, J. S. Frank, G. A. Mottino, M. Hendizadeh, A. Hakhamian, J. H. Tillisch, S. T. Reddy, M. Navab, G. M. Anantharamaiah, L. J. Ignarro, et al.
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet
J. Lipid Res., October 1, 2006; 47(10): 2148 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. W. Cruise, J. R. Lukens, A. P. Nguyen, M. G. Lassen, S. N. Waggoner, and Y. S. Hahn
Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4+ T Cell-Dependent Liver Damage
J. Immunol., May 15, 2006; 176(10): 6235 - 6244.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Tesse, M. C. Martinez, B. Hugel, K. Chalupsky, C. D. Muller, F. Meziani, D. Mitolo-Chieppa, J.-M. Freyssinet, and R. Andriantsitohaina
Upregulation of Proinflammatory Proteins Through NF-{kappa}B Pathway by Shed Membrane Microparticles Results in Vascular Hyporeactivity
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2522 - 2527.
[Abstract] [Full Text] [PDF]